These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 18480003)
41. Genotyping of CYP2C9 and VKORC1 polymorphisms predicts south Indian patients with deep vein thrombosis as fast metabolizers of warfarin/acenocoumarin. Arunkumar G; Vishnuprabu D; Nupur B; Vidyasagaran T; Murugan AK; Munirajan AK Drug Discov Ther; 2017; 11(4):198-205. PubMed ID: 28867752 [TBL] [Abstract][Full Text] [Related]
42. The Creating an Optimal Warfarin Nomogram (CROWN) Study. Perlstein TS; Goldhaber SZ; Nelson K; Joshi V; Morgan TV; Lesko LJ; Lee JY; Gobburu J; Schoenfeld D; Kucherlapati R; Freeman MW; Creager MA Thromb Haemost; 2012 Jan; 107(1):59-68. PubMed ID: 22116191 [TBL] [Abstract][Full Text] [Related]
43. The long and winding road to warfarin pharmacogenetic testing. Ginsburg GS; Voora D J Am Coll Cardiol; 2010 Jun; 55(25):2813-5. PubMed ID: 20579536 [No Abstract] [Full Text] [Related]
44. A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunity. Kim MJ; Huang SM; Meyer UA; Rahman A; Lesko LJ J Clin Pharmacol; 2009 Feb; 49(2):138-46. PubMed ID: 19179293 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of genetic factors for warfarin dose prediction. Caldwell MD; Berg RL; Zhang KQ; Glurich I; Schmelzer JR; Yale SH; Vidaillet HJ; Burmester JK Clin Med Res; 2007 Mar; 5(1):8-16. PubMed ID: 17456829 [TBL] [Abstract][Full Text] [Related]
46. VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients. Obayashi K; Nakamura K; Kawana J; Ogata H; Hanada K; Kurabayashi M; Hasegawa A; Yamamoto K; Horiuchi R Clin Pharmacol Ther; 2006 Aug; 80(2):169-78. PubMed ID: 16890578 [TBL] [Abstract][Full Text] [Related]
47. Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes. Wen MS; Lee M; Chen JJ; Chuang HP; Lu LS; Chen CH; Lee TH; Kuo CT; Sun FM; Chang YJ; Kuan PL; Chen YF; Charng MJ; Ray CY; Wu JY; Chen YT Clin Pharmacol Ther; 2008 Jul; 84(1):83-9. PubMed ID: 18183038 [TBL] [Abstract][Full Text] [Related]
49. Genotyping three SNPs affecting warfarin drug response by isothermal real-time HDA assays. Li Y; Jortani SA; Ramey-Hartung B; Hudson E; Lemieux B; Kong H Clin Chim Acta; 2011 Jan; 412(1-2):79-85. PubMed ID: 20854800 [TBL] [Abstract][Full Text] [Related]
50. CYP2C9 and VKORC1 genetic polymorphism analysis might be necessary in patients with Factor V Leiden and prothrombin gene G2021A mutation(s). Leung A; Huang CK; Muto R; Liu Y; Pan Q Diagn Mol Pathol; 2007 Sep; 16(3):184-6. PubMed ID: 17721328 [TBL] [Abstract][Full Text] [Related]
51. Combination of phenotype assessments and CYP2C9-VKORC1 polymorphisms in the determination of warfarin dose requirements in heavily medicated patients. Michaud V; Vanier MC; Brouillette D; Roy D; Verret L; Noel N; Taillon I; O'Hara G; Gossard D; Champagne M; Goodman K; Renaud Y; Brown A; Phillips M; Ajami AM; Turgeon J Clin Pharmacol Ther; 2008 May; 83(5):740-8. PubMed ID: 18030307 [TBL] [Abstract][Full Text] [Related]
52. Will there be a role for genotyping in warfarin therapy? Gandara E; Wells PS Curr Opin Hematol; 2010 Sep; 17(5):439-43. PubMed ID: 20601874 [TBL] [Abstract][Full Text] [Related]
53. Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery. Gulseth MP; Grice GR; Dager WE Am J Health Syst Pharm; 2009 Jan; 66(2):123-33. PubMed ID: 19139476 [TBL] [Abstract][Full Text] [Related]
54. Exploring warfarin pharmacogenomics with the extreme-discordant-phenotype methodology: impact of FVII polymorphisms on stable anticoagulation with warfarin. Fuchshuber-Moraes M; Perini JA; Rosskopf D; Suarez-Kurtz G Eur J Clin Pharmacol; 2009 Aug; 65(8):789-93. PubMed ID: 19387626 [TBL] [Abstract][Full Text] [Related]
59. Genotype and adverse drug reactions to warfarin. Byron KA; Dear AE Med J Aust; 2007 Jul; 187(1):61-2. PubMed ID: 17605718 [No Abstract] [Full Text] [Related]
60. Refining the use of warfarin through genetic testing. Lee SC Int Angiol; 2008 Aug; 27(4):271-3. PubMed ID: 18677287 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]